India  

Experts question govt vaccine purchase price, say it’s higher

IndiaTimes Thursday, 14 January 2021 ()
As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s purchases of Serum Institute of India and Bharat Biotech’s vaccines were “overpriced”.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

This dog arrived in elevator for a walk by a neighbor while the owner has COVID [Video]

This dog arrived in elevator for a walk by a neighbor while the owner has COVID

This woman unexpectedly became a dog walker for a stranger in her apartment building in Poland while the dog's owner is quarantining with COVID-19.

Credit: USA Today News (International)    Duration: 00:35Published
Coronavirus in numbers: UK death toll reaches 89,860 [Video]

Coronavirus in numbers: UK death toll reaches 89,860

Public Health England said a further 599 people had died within 28 days oftesting positive for Covid-19 in the UK as of Monday.

Credit: PA - Press Association STUDIO    Duration: 00:37Published

COVID-19: Two dead after receiving shot, govt says deaths not linked to vaccine

Since the beginning of the COVID-19 vaccination drive in India on January 16, 580 adverse events were observed and seven people were hospitalised.
DNA

England in Six Nations: Jason Ryles absent because of Covid-19 travel fears

Assistant coach Jason Ryles will not be with England for the Six Nations because of travel concerns but hopes to re-join the staff for the summer fixtures.
BBC Sport
580 adverse events reported post-COVID immunisation: Health Ministry [Video]

580 adverse events reported post-COVID immunisation: Health Ministry

Additional Secretary of Health Ministry Manohar Agnani informed that a total of 580 adverse events were reported post-vaccination drive. He said, "A cumulative of 580 Adverse Events Following Immunisation (AEFIs) has been reported. Of which 7 have been hospitalised."

Credit: ANI    Duration: 01:03Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

India may get four more COVID-19 vaccines soon, SII says work in progress

According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
DNA
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

The Times of India The Times of India Indian English-language daily newspaper

64% vaccine turnout after 2 days, government expects footfall to rise

Four states — Tamil Nadu, Punjab, Tripura and Puducherry — recorded low turnout of beneficiaries in the range of 22-34%, whereas other states reported more..
IndiaTimes

QR-coded ‘vaccine pass’ may help in foreign travel

A ‘vaccination certificate’ with a QR code, which acts as a digital pass or a ‘facilitating tool’, can work not just within the country but abroad too, a..
IndiaTimes

Related videos from verified sources

Questions About the U.K.’s Mutated COVID-19 Strain: Answered [Video]

Questions About the U.K.’s Mutated COVID-19 Strain: Answered

Questions About the U.K.’s Mutated COVID-19 Strain:, Answered. A new, potentially more contagious strand of COVID-19 has been identified in the U.K. and is causing worldwide panic. . The variant,..

Credit: Wibbitz Top Stories     Duration: 01:36Published
Govt prioritized 30 crore people for COVID vaccine in phase-1: Harsh Vardhan [Video]

Govt prioritized 30 crore people for COVID vaccine in phase-1: Harsh Vardhan

After consultation with experts, government prioritized 30 crore people for COVID vaccine, informed Union Health Minister Dr Harsh Vardhan in an exclusive interview with ANI. He said, "After..

Credit: ANI     Duration: 02:32Published

Related news from verified sources

Dollar General will pay employees to get Covid-19 vaccine

Dollar General said it will pay employees to get a Covid-19 vaccine. The discounter will provide frontline hourly workers with a one-time payment equivalent to...
bizjournals Also reported by •InvezzVOA NewsGothamistDaily RecordZee News

WHO chief lambasts vaccine profits, demands elderly go first

GENEVA (AP) — The World Health Organization chief on Monday lambasted drugmakers' profits and vaccine inequalities, saying it’s “not right” that younger,...
SeattlePI.com Also reported by •WorldNews

Israel trades Pfizer doses for medical data in vaccine blitz

JERUSALEM (AP) — After sprinting ahead in the race to inoculate its population against the coronavirus, Israel has struck a deal with Pfizer, promising to...
SeattlePI.com Also reported by •Invezz